Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
Sales | 345 | 318 | 291 | 529 | 518 |
Gross Profit | 345 | 318 | 291 | 529 | 518 |
Operating Expenses | 2,953 | 2,690 | 2,058 | 1,956 | 2,020 |
Operating Income | -2,608 | -2,372 | -1,767 | -1,427 | -1,501 |
Interest Expense | 0 | 0 | 0 | 2 | 43 |
Other Income | -520 | -6,333 | 0 | 0 | 0 |
Pre-tax Income | -3,128 | -8,705 | -1,767 | -1,430 | -1,544 |
Net Income Continuous | -3,128 | -8,705 | -1,767 | -1,430 | -1,544 |
Net Income | $-3,128 | $-8,705 | $-1,767 | $-1,430 | $-1,544 |
EPS Basic Total Ops | 0.00 | -479.04 | N/A | 0.00 | 0.00 |
EPS Basic Continuous Ops | -220.20 | -641.61 | -118.49 | -115.12 | -126.72 |
EPS Diluted Total Ops | 0.00 | -479.04 | N/A | 0.00 | 0.00 |
EPS Diluted Continuous Ops | -220.20 | -641.61 | -118.49 | -115.12 | -126.72 |
EBITDA(a) | $-2,586 | $-2,351 | $-1,754 | $-1,324 | $-1,365 |